跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
麻醉學科
醫學院
醫學系
電話
+886-2-27361661#3111~3114
電子郵件
[email protected]
網站
http://medschool.tmu.edu.tw/main.php
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(13)
專案
(117)
研究成果
(726)
資料集
(9)
指紋
查看啟用 麻醉學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cohort Analysis
100%
Odds Ratio
71%
Retrospective Cohort Study
57%
Hazard Ratio
54%
Adverse Outcome
45%
Meta-Analysis
44%
Randomized Controlled Trial
37%
Apoplexy
37%
Major Surgery
28%
Systematic Review
26%
Analgesia
23%
General Anesthesia
22%
Postoperative Complication
20%
Adverse Event
20%
Diabetes
20%
Postoperative Pain
19%
Pneumonia
17%
Alopecia Areata
17%
Cancer Surgery
16%
Intensive Care Unit
15%
Inflammation
15%
Epidural Analgesia
14%
Hospital Mortality
14%
Propensity Score Matching
13%
Surgical Mortality
13%
End Stage Renal Disease
12%
Morphine
11%
Acute Kidney Injury
11%
Proportional Hazards Model
11%
Comorbidity
11%
Intravenous Patient-Controlled Analgesia
11%
Neuraxial Anesthesia
10%
Traditional Chinese Medicine
10%
Pediatrics
10%
Acupuncture Treatment
10%
Spinal Anaesthesia
10%
Diseases
10%
Logistic Regression Analysis
10%
Sevoflurane
10%
Cesarean Section
10%
Noncardiac Surgery
10%
Rectum Cancer
10%
Overall Survival
10%
Epilepsy
10%
Septicemia
10%
Geriatrics
9%
Injection
9%
Recurrent Disease
9%
Non Small Cell Lung Cancer
9%
Malignant Neoplasm
9%
Myocardial Infarction
9%
Nerve Block
9%
Local Anesthetic
8%
Case-Control Study
8%
Chronic Kidney Disease
8%
Disease Specific Survival
8%
Influenza Vaccination
8%
Hepatocellular Carcinoma
8%
Video-Assisted Thoracoscopic Surgery
8%
Prevalence
8%
Oral
8%
Nasopharynx Carcinoma
8%
Dental Scaling
8%
Desflurane
8%
Heart Surgery
8%
Chemoradiotherapy
8%
Morbidity
8%
Fatty Acid Desaturation
8%
Bispectral Index
7%
Nephropathy
7%
Patient with Diabetes
7%
Sepsis
7%
Nuclear Factor
7%
Body Mass Index
7%
Cancer Recurrence
7%
Urinary Tract Infection
7%
Mortality Rate
7%
Observational Study
7%
Tracheal Intubation
7%
Colorectal Carcinoma
7%
Dry Eye
7%
Blood Transfusion
7%
Lung Injury
7%
Hyperlipidemia
7%
Diabetes Mellitus
7%
Colon Carcinoma
6%
Atopic Dermatitis
6%
Bupivacaine
6%
Cardiopulmonary Bypass
6%
Acute Heart Infarction
6%
Ischemic Heart Disease
6%
Hemodynamic
6%
Parkinson's Disease
6%
Intubation
6%
Myasthenia gravis
6%
Health Care
6%
Thorax Surgery
6%
Propofol
6%
Lipopolysaccharide
6%
Eye Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
90%
Rat
60%
Cerebrovascular Accident
43%
Lipopolysaccharide
40%
Nitric Oxide
28%
Nuclear Factor
26%
Ketamine
24%
Cytochrome P450
24%
Alternative Complement Pathway C3 C5 Convertase
21%
Messenger RNA
20%
Randomized Controlled Trial
20%
Cytokine
18%
Propofol
18%
Inflammation
18%
Sepsis
17%
Endotoxin
17%
Toll Like Receptor 4
15%
Cardiovascular Disease
14%
Unspecific Monooxygenase
14%
Adverse Event
13%
Lung Injury
13%
Interleukin 1
13%
Liver Cell Carcinoma
13%
End Stage Renal Disease
13%
Diabetes Mellitus
13%
Protein Kinase B
13%
Tumor Necrosis Factor
12%
Inducible Nitric Oxide Synthase
11%
Phosphatidylinositol 3 Kinase
10%
Diseases
10%
Malignant Neoplasm
10%
Nitroprusside Sodium
10%
Therapeutic Effect
10%
Dexmedetomidine
10%
Lidocaine
10%
Chronic Kidney Failure
10%
Influenza
10%
Interleukin 6
10%
Mitogen Activated Protein Kinase
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Reactive Oxygen Metabolite
9%
Adverse Outcome
9%
Morphine
9%
Caspase
9%
Alopecia Areata
9%
Epilepsy
8%
Acute Kidney Failure
8%
microRNA
8%
Liver Cirrhosis
8%
Psoriasis
8%
Statin (Protein)
8%
Estrogen Receptor Alpha
8%
Magnesium Sulfate
8%
Vaccination
8%
Analgesic Agent
8%
Antiinflammatory Activity
8%
Heme Oxygenase 1
8%
Western Blot
7%
Phosphotransferase
7%
Blood-Brain Barrier
7%
Glioblastoma
7%
Pneumonia
7%
Diethylstilbestrol
7%
Brain Ischemia
7%
Ethoxyresorufin
7%
Postoperative Pain
7%
Streptozotocin
7%
Traditional Chinese Medicine
7%
Transcription Factor AP 1
7%
Toll Like Receptor 2
7%
Breast Cancer
6%
Cancer Growth Factor
6%
Cytochrome P450 1A
6%
Liver Injury
6%
Antiplatelet
6%
Cytotoxicity
6%
Hemorrhagic Shock
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Dexamethasone
6%
Caspase 3
6%
Hypoxia
6%
Honokiol
6%
Sore Throat
6%
Alkaloid
6%
Genistein
6%
Autoimmune Skin Disease
6%
Chronic Obstructive Lung Disease
6%
Glioma
6%
Parkinson's Disease
6%
Hyperlipidemia
6%
Red Yeast Rice
6%
Levobupivacaine
6%
Rutaecarpine
6%
Ischemia
6%
All Cause Mortality
5%
Postoperative Nausea and Vomiting
5%
Alkaline Phosphatase
5%
Receptor
5%
Hepatitis C
5%
Acute Lung Injury
5%
Nursing and Health Professions
Confidence Interval
86%
Cohort Analysis
74%
Odds Ratio
54%
Cerebrovascular Accident
45%
Propensity Score
34%
Hazard Ratio
31%
Adverse Outcome
26%
Meta Analysis
22%
National Health Insurance
19%
Systematic Review
19%
Prevalence
19%
Cancer Surgery
16%
Alopecia Areata
14%
Logistic Regression Analysis
11%
Recurrent Disease
11%
Major Surgery
11%
Epidural Analgesia
10%
Comorbidity
10%
Proportional Hazards Model
9%
Perioperative
9%
Cross-Sectional Study
9%
Postoperative Complication
9%
Postoperative Pain
9%
Liver Cirrhosis
9%
Overall Survival
8%
General Anesthesia
8%
Blood Transfusion
8%
Chronic Kidney Failure
8%
Colorectal Carcinoma
8%
Cancer Recurrence
8%
Adverse Event
7%
Diseases
7%
Hospital Mortality
7%
Health Care
7%
Gerontology
7%
Propofol
7%
Non Small Cell Lung Cancer
7%
Anesthesist
6%
Cigarette Filter
6%
Septicemia
6%
Intensive Care Unit
6%
Parkinson's Disease
6%
Clinical Outcome
6%
Elevated Blood Pressure
6%
Sepsis
6%
Hypertension
6%
Postoperative Nausea and Vomiting
6%
Patient Controlled Analgesia
5%
Epilepsy
5%
Economic and Social Development
5%
Mortality Rate
5%
Sedation
5%
Opioid
5%
Waist Circumference
5%
Prehypertension
5%
Surgical Mortality
5%